Treatment with basic fibroblast growth factorincorporated gelatin hydrogel does not exacerbate mechanical allodynia after spinal cord contusion injury in rats

Journal of Spinal Cord Medicine

Volumn 36, Issue 2, 2013, Pages 134-139

  Furuya, Takeo ^a   Hashimoto, Masayuki ^a   Koda, Masao ^a   Murata, Atsushi ^a   Okawa, Akihiko ^a   Dezawa, Mari ^b   Matsuse, Dai ^b   Tabata, Yasuhiko ^c   Takahashi, Kazuhisa ^a   Yamazaki, Masashi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Allodynia; Basic fibroblast growth factor; Locomotor recovery; Motor deficits; Neuroprotection; Paraplegia; Scaffold; Spinal cord injuries

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GELATIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; DISEASE EXACERBATION; DRUG SAFETY; FEMALE; HYDROGEL; LATENT PERIOD; LOCOMOTION; MOTOR ACTIVITY; NONHUMAN; RAT; ROTAROD TEST; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; GELATIN; HYDROGELS; HYPERALGESIA; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84877607882     PISSN: 10790268     EISSN: 20457723     Source Type: Journal    
DOI: 10.1179/2045772312Y.0000000030     Document Type: Article

References (16)

1. Furuya T, Hashimoto M, Koda M, Okawa A, Murata A, Takahashi K, et al. Treatment of rat spinal cord injury with a Rho-kinase inhibitor and bone marrow stromal cell transplantation. Brain Res 2009;1295:192-202.
2. Marui A, Tabata Y, Kojima S, Yamamoto M, Tambara K, Nishina T, et al. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. Circ J 2007;71(8): 1181-6.
3. Iwakura A, Fujita M, Kataoka K, Tambara K, Sakakibara Y, Komeda M, et al. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 2003;18(2):93-9.
4. Iwakura A, Tabata Y, Miyao M, Ozeki M, Tamura N, Ikai A, et al. Novel method to enhance sternal healing after harvesting bilateral internal thoracic arteries with use of basic fibroblast growth factor. Circulation 2000;102(19 Suppl. 3):III307-11.
5. Aimoto T, Uchida E, Matsushita A, Tabata Y, Takano T, Miyamoto M, et al. Controlled release of basic fibroblast growth factor promotes healing of the pancreaticojejunal anastomosis: a novel approach toward zero pancreatic fistula. Surgery 2007; 142(5):734-40.
6. Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 1995;65(4):1740-51.
7. Kirschner PB, Henshaw R, Weise J, Trubetskoy V, Finklestein S, Schulz JB, et al. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J Cereb Blood Flow Metab 1995;15(4):619-23.
8. Anderson KJ, Dam LS, Cotman CW. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 1998;332(6162):360-1.
9. Teng YD, Mocchetti I, Wrathall Jr. Basic and acidic fibloblast growth factors protect spinal motor neurons in vivo after experimental spinal cord injury. Eur J Neurosci 1998;10(2):798-802.
10. Itosaka H, Kuroda S, Shichinohe H, Yasuda H, Yano S, Kamei S, et al. Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering. Neuropathology 2009; 29(3):248-57.
11. Johnson PJ, Tatara A, Shiu A, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 and platelet derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant 2010;19(1):89-101.
12. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12(1):1-21.
13. Mocchetti I, Rabin SJ, Colangelo AM, Whittemore SR, Wrathall Jr. Increased basic fibroblast growth factor expression following contusive spinal cord injury. Exp Neurol 1996;141(1):154-64.
14. Zai LJ, Yoo S, Wrathall Jr. Increased growth factor expression and cell proliferation after contusive spinal cord injury. Brain Res 2005;1052(2):147-55.
15. Lee YL, Shih K, Bao P, Ghirnikar RS, Eng LF. Cytokine chemokine expression in contused rat spinal cord. Neurochem Int 2000; 36(4-5):417-25.
16. Jimenez Hamann MC, Tator CH, Shoichet MS. Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord. Exp Neurol 2005; 194(1):106-19.